Bleomycin (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Bleomycin drug offered from Fresenius Kabi USA, LLC. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: BLEOMYCIN SULFATE
SUBSTANCE NAME: BLEOMYCIN SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytoprotective Agent [EPC]
ROUTE: INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2009-02-13
END MARKETING DATE: 0000-00-00


Bleomycin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBleomycin from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 15([USP’U]/1)
START MARKETING DATE: 2009-02-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-136_cc1c6955-a909-4103-bc38-11cc9b96c84e
PRODUCT NDC: 63323-136
APPLICATION NUMBER: ANDA065185

Other BLEOMYCIN SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal BiosciencesBleomycin
Fresenius Kabi USA, LLCBleomycin
Hospira, Inc.Bleomycin
Teva Parenteral Medicines, Inc.Bleomycin